PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas

Laimer, D; Dolznig, H; Kollmann, K; Vesely, PW; Schlederer, M; Merkel, O; Schiefer, AI; Hassler, MR; Heider, S; Amenitsch, L; Thallinger, C; Staber, PB; Simonitsch-Klupp, I; Artaker, M; Lagger, S; Turner, SD; Pileri, S; Piccaluga, PP; Valent, P; Messana, K; Landra, I; Weichhart, T; Knapp, S; Shehata, M; Todaro, M; Sexl, V; Hofler, G; Piva, R; Medico, E; Ruggeri, BA; Cheng, MG; Eferl, R; Egger, G; Penninger, JM; Jaeger, U; Moriggl, R; Inghirami, G; Kenner, L NAT MED. 2012; 18(11): 1699-+.

Histiocytic sarcoma – targeted therapy: novel therapeutic options? A series of 4 cases.

Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W Onkologie. 2012; 35(7-8):447-450

GHRH antagonist when combined with cytotoxic agents induces S-phase arrest and additive growth inhibition of human colon cancer

Rick, FG; Seitz, S; Schally, AV; Szalontay, L; Krishan, A; Datz, C; Stadlmayr, A; Buchholz, S; Block, NL; Hohla, F CELL CYCLE. 2012; 11(22): 4203-4210.

LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.

Schimanski, CC; Möhler, M; Schön, M; van Cutsem, E; Greil, R; Bechstein, WO; Hegewisch-Becker, S; von Wichert, G; Vöhringer, M; Heike, M; Heinemann, V; Peeters, M; Kanzler, S; Kasper, S; Overkamp, F; Schröder, J; Seehofer, D; Kullmann, F; Linz, B; Schmidtmann, I; Smith-Machnow, V; Gockel, I; Lang, H; Galle, PR; BMC Cancer. 2012; 12:144

Antagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinases.

Rick, FG; Schally, AV; Szalontay, L; Block, NL; Szepeshazi, K; Nadji, M; Zarandi, M; Hohla, F; Buchholz, S; Seitz, S; Proc Natl Acad Sci U S A. 2012; 109(5):1655-1660

Treating T-cell lymphoma: is there a light at the end of the tunnel?_x000D_

Hopfinger, G; Merkel, O; Melchardt, T; Greil, R; Magazine of European Medical Oncology. 2012; 5 (3): 174-177.

48-jähriger Patient mit fokal fortgeschrittenem, distalem Ösophaguskarzinom – Beispiel einer geglückten interdisziplinären Zusammenarbeit

Hohla, F; Vaszi, A; Datz, L; Rettenbacher, L; Hutter, J; Tumorboard. 2012; 1(1): 27-30.

[Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].

Pabinger, I; Gastl, G; Steurer, M; Sormann, S; Fillitz, M; Friedl, J; Geissler, D; Geissler, K; Greil, R; Knöbl, P; Kozek-Langenecker, S; Krippl, P; Kyrle, P; Lang, A; Linkesch, W; Ludwig, H; Müller, M; Panzer, S; Pittermann, E; Thaler, J; Weltermann, A; WIEN KLIN WOCHENSCHR. 2012; 124(3-4): 111-123.

Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)

Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B BONE MARROW TRANSPL. 2013; 48: S393-S393.

Updated report of the Austrian CML registry

Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlogl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Hausler, C; Woll, E; Oexle, H; Schnallinger, M; Pober, M; Rochau, U; Siebert, U; Thaler, J; Gastl, G ONKOLOGIE. 2013; 36: 63-63.